Mangoceuticals (MGRX) Notes Payables (2022 - 2025)
Mangoceuticals' (MGRX) quarterly Notes Payables came in at $100000.0 in Q3 2025, little changed quarter-over-quarter from $100000.0 in Q2 2025.
Mangoceuticals (MGRX) Notes Payables (2022 - 2025) Analysis & Trends
Mangoceuticals has disclosed Notes Payables across 3 years of filings, most recently posting $100000.0 for Q3 2025.
- Notes Payables for Q3 2025 came in at $100000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $100000.0 (changed N/A YoY), and the FY2024 annual result was $150000.0, changed N/A from the prior year.
- Notes Payables came in at $100000.0 for Q3 2025 at Mangoceuticals, roughly flat from $100000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $150000.0 in Q4 2024 to a low of $78260.0 in Q4 2022.
- The 3-year median for Notes Payables is $100000.0 (2025), against an average of $103152.0.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Dec 31, 2024 | 150,000.00 |
| Mar 31, 2024 | 87,500.00 |
| Dec 31, 2022 | 78,260.00 |